[Product Releases]
|
|
|
|
|
[Blog]
|
|
Most recent post
|
[News]
|
|
IBM's Systems & Technology Group releases a white paper with
eHiTS & Cell
Oct 2008 Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database
Sept 2010
EPA's ToxCastTM project will use SimBioSys' eHiTS as docking engine
Nov, 2007
|
[Events]
|
| 240th ACS
Aug 22-26, 2010
Boston, MA, USA
booth #945
see >> more
|
|
|
|
|
Company Info
Background
SimBioSys Inc. was incorporated in 1996 as a side venture fom the
Institute for Computer Appliactions in Molecular Sciences (ICAMS) at
the University of Leeds, UK.
Since becoming incorporated, the first 4 years were devoted to the
development of technology infrastructure MoDeST (Molecular Design Software Toolkit). The next years were
focused on application development and today SimBioSys is
ready to market new products such as eHiTS, LASSO, ARChem etc. all developed on its molecular modelling platform: MoDeST
Company Profile
SimBioSys develops 3-dimensional molecular modelling software for the
pharmaceutical drug discovery industry.
The products and services are developed with the following goals in
mind:
- acceleration of the drug discovery process
- increasing the speed and accuracy of drug R&D
- increasing the quality of research decisions
The Company's Vision
SimBioSys envisions being a leader in providing the highest quality and
performance interactive visual design software for the biomolecular
sciences.
The company's aim revolves around its mission statement: Reality3 - to be realistic in all three
dimensions:
- fully interactive real-time
software
- using realistic
scientific simulations
- packaged together to provide the most realistic visualization possible.
|
|
|
